B

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Executive National Director - US Field Medical Oncology, CELMoDs

Biology & BiotechConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA

About the Job

Requirements

  • An advanced scientific degree (MD, PharmD, PhD, or DNP) is required; a science graduate with extensive relevant pharmaceutical experience may also be considered. An MBA is a plus.
  • At least 10 years of clinical and/or pharmaceutical experience, including Oncology Medical Affairs expertise, and at least 8 years of Field Medical experience with demonstrated exceptional performance in leadership, people management, and medical planning.
  • Familiarity with all phases of drug development, including clinical development, regulatory affairs, and product lifecycle management.
  • Launch expertise in oncology drugs.
  • At least 3 years of people-management experience in previous positions.
  • Ability to lead national field medical projects or initiatives at an executive level.
  • Demonstrated account-management ability.
  • Ability to build, develop, lead, and coach diverse, results-oriented, high-performance teams.
  • Experience working in cross-functional and matrixed teams, managing multiple projects and priorities in ambiguous environments, and leading and executing autonomously.
  • Ability to partner, collaborate, influence, and negotiate effectively.
  • Excellent verbal and written communication skills in English, including the ability to communicate, listen, and answer questions effectively.
  • Experience in change leadership.
  • In-depth knowledge of the disease area, including key scientific publications.
  • Understanding of customer (healthcare professional and payer) and patient needs.
  • Knowledge of principles and implications of pharmacoeconomic data.
  • Knowledge of the US healthcare system and pharmaceutical industry, including laws, regulations, and guidelines developed by state and federal bodies such as the FDA, OIG, PhRMA, and OPDP.
  • Knowledge of regional key institutions, integrated delivery networks, and health systems.
  • Knowledge of clinical trial design and the processes and procedures required for clinical activities.
  • Knowledge of all relevant compliance standards.
  • Successful prior service as a Product Point, JV Point, or Launch Point.
  • Strong strategic-thinking skills demonstrated and documented in previous performance reviews.

Responsibilities

  • Own end-to-end accountability for developing and executing the national Field Medical plan for the CELMoDs portfolio, aligning it with the US Medical Oncology Strategy Plan and commercial priorities across clinical development and commercialization.
  • Set clear, challenging, and measurable goals for the field organization, consistent with ASMART principles, and hold direct reports accountable to performance milestones with transparency and urgency.
  • Measure, assess, and communicate the effectiveness of CELMoDs Field Medical activities to the broader organization; identify gaps and drive timely course corrections with US Field Medical Oncology leadership.
  • Ensure effective execution of scientific exchange, omnichannel healthcare professional engagement, and field medical programs across the CELMoDs portfolio, including pre- and post-approval activities.
  • Develop and manage the CELMoDs oncology Field Medical budget in collaboration with the Vice President of US Field Medical Oncology.
  • Ensure team activities, customer relationship management responsibilities, and business processes, including audits, are completed rigorously and in compliance with BMS policies, Good Clinical Practice, FDA regulations, and legal and ethical standards.
  • Oversee and ensure that field teams and local-study investigators understand and apply pharmacovigilance procedures.
  • Directly manage the Regional Directors and/or Regional Associate Directors who lead the field Medical Science Liaison organization supporting CELMoDs.
  • Coach direct reports through field rides, structured feedback, and individualized development plans to improve performance.
  • Build, develop, and lead a diverse, high-performing field medical organization that operates with accountability, scientific credibility, and a patient-first mindset.
  • Foster continuous learning, constructive challenge, and innovation aligned with BMS values.
  • Partner with the Worldwide Learning Organization to identify training needs and ensure Medical Science Liaisons can communicate the science of the CELMoDs pipeline accurately and confidently.
  • Lead succession planning and talent development as strategic priorities within the field medical organization.
  • Ensure direct reports and their teams comply with applicable guidelines, FDA regulations, and BMS ethical and legal standards.
  • Represent CELMoDs Field Medical in US Oncology Medical Strategy, translating field insights from healthcare professional interactions into actionable intelligence for medical and commercial stakeholders.
  • Engage thought leaders and key opinion leaders across assigned hematologic malignancies to assess the medical landscape, understand unmet needs, and inform strategy development; validate thought-leader lists and appropriate healthcare professional segmentation.
  • Ensure Medical Science Liaisons collect high-quality, synthesized, strategic medical insights and provide them to the home office in a timely, structured manner.
  • Collaborate across the CELMoDs matrix, US Oncology Commercialization organization, and Global Medical Oncology Leads and Disease Area Heads to execute medical strategies effectively.
  • Ensure cross-functional institution and account-planning approaches are adopted across the field team, integrating Commercial, Health Economics and Outcomes Research, Market Access, Clinical Development, and Patient Advocacy perspectives.
  • Provide medical and scientific updates and support to internal stakeholders, including Commercial, Regulatory, Pharmacovigilance, Legal, Compliance, Health Economics and Outcomes Research, and Market Access.
  • Champion the adoption and effective use of artificial intelligence and digital tools across the field medical team to improve healthcare professional engagement, insight generation, and field execution.
  • Use AI-powered analytics and customer relationship management platforms to optimize thought-leader identification, segmentation, and outreach and enable data-driven omnichannel engagement aligned with healthcare professional preferences.
  • Promote generative AI for literature synthesis, scientific-content preparation, and medical-information response workflows in compliance with BMS AI governance policies.
  • Build digital fluency and AI literacy across the team and ensure Medical Science Liaisons are trained to use emerging tools for personalized scientific interactions.
  • Partner with home-office functions to identify and scale AI-enabled capabilities that measurably improve field medical productivity and impact.
  • Oversee appropriate field support for BMS- and contract research organization-sponsored CELMoDs clinical trials, including site-feasibility recommendations, patient-recruitment support, and investigator engagement across trial phases.
  • Ensure Medical Science Liaisons serve as primary liaisons to investigators interested in Investigator-Sponsored Research, facilitating submission support in alignment with home-office medical and US Market Guiding Principles.
  • Provide Clinical Development with study and site-feasibility recommendations and insights based on field knowledge and investigator relationships.
  • Ensure Medical Science Liaisons and healthcare professionals understand BMS research data and the science underlying CELMoDs assets to support safe and effective use across the product lifecycle.

Desired Qualifications

  • Experience supporting novel modalities, such as protein degraders or CELMoDs.
  • An MBA.
  • A broad range of experience in other therapeutic areas and/or other industry functions.

About the Company

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Bristol Myers Squibb discovers, develops and sells prescription medicines for serious illnesses, including cancer, blood disorders, immune diseases and heart disease, for patients treated by doctors and hospitals around the world. Its best-known drug is Opdivo, an immunotherapy that helps the body's own immune system find and attack many kinds of cancer. Researchers develop drug candidates in its labs or bring them in through acquisitions and partnerships, then test them in clinical trials to win regulatory approval. The company makes and markets the approved medicines and earns its revenue from sales of patent-protected drugs. Its roots go back to a business founded in 1887, and it is based in Lawrence Township, New Jersey.

Company size
10,001+
Company stage
IPO
Headquarters
Lawrence Township, NJ
Founded
1887

Recently Posted Jobs

Explore more opportunities at Bristol Myers Squibb

See more jobs